Aspen Pharmacare (OTCMKTS:APNHY – Get Free Report) shares reached a new 52-week high on Tuesday . The company traded as high as $9.41 and last traded at $9.41, with a volume of 192 shares traded. The stock had previously closed at $8.71.
Aspen Pharmacare Price Performance
The stock’s 50 day moving average price is $8.61 and its 200-day moving average price is $7.75. The company has a debt-to-equity ratio of 0.36, a current ratio of 3.64 and a quick ratio of 2.66.
About Aspen Pharmacare
Aspen Pharmacare Holdings Limited is a multinational pharmaceutical company headquartered in Durban, South Africa. Founded in 1997 by Stephen Saad and Gus Attridge, Aspen has grown from a regional generic drug producer into a global specialist in branded and generic medicines. The company is publicly traded on the Johannesburg Stock Exchange and its American depositary receipts trade over‐the‐counter under the symbol APNHY.
Aspen’s core business encompasses the development, manufacture and distribution of a broad portfolio of injectable and oral pharmaceutical products.
Featured Stories
- Five stocks we like better than Aspen Pharmacare
- NextEra’s Dominion Deal Could Put It at the Center of the AI Power Race
- Amazon Could Be About to Reap the Rewards of a Software Spending Boom
- Best Buy’s Turnaround Is Gaining Traction, But Wall Street Still Needs Proof
- AI Fears Hit Nebius Stock, But Has the Growth Thesis Changed?
Receive News & Ratings for Aspen Pharmacare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Pharmacare and related companies with MarketBeat.com's FREE daily email newsletter.
